BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10049061)

  • 1. The role of TEL fusion genes in pediatric leukemias.
    Rubnitz JE; Pui CH; Downing JR
    Leukemia; 1999 Jan; 13(1):6-13. PubMed ID: 10049061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
    McLean TW; Ringold S; Neuberg D; Stegmaier K; Tantravahi R; Ritz J; Koeffler HP; Takeuchi S; Janssen JW; Seriu T; Bartram CR; Sallan SE; Gilliland DG; Golub TR
    Blood; 1996 Dec; 88(11):4252-8. PubMed ID: 8943861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.
    Borkhardt A; Cazzaniga G; Viehmann S; Valsecchi MG; Ludwig WD; Burci L; Mangioni S; Schrappe M; Riehm H; Lampert F; Basso G; Masera G; Harbott J; Biondi A
    Blood; 1997 Jul; 90(2):571-7. PubMed ID: 9226156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.
    Uphoff CC; MacLeod RA; Denkmann SA; Golub TR; Borkhardt A; Janssen JW; Drexler HG
    Leukemia; 1997 Mar; 11(3):441-7. PubMed ID: 9067587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.
    Seeger K; Adams HP; Buchwald D; Beyermann B; Kremens B; Niemeyer C; Ritter J; Schwabe D; Harms D; Schrappe M; Henze G
    Blood; 1998 Mar; 91(5):1716-22. PubMed ID: 9473238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.
    Golub TR; Barker GF; Bohlander SK; Hiebert SW; Ward DC; Bray-Ward P; Morgan E; Raimondi SC; Rowley JD; Gilliland DG
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4917-21. PubMed ID: 7761424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion.
    Romana SP; Mauchauffé M; Le Coniat M; Chumakov I; Le Paslier D; Berger R; Bernard OA
    Blood; 1995 Jun; 85(12):3662-70. PubMed ID: 7780150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization.
    Tsuzuki S; Karnan S; Horibe K; Matsumoto K; Kato K; Inukai T; Goi K; Sugita K; Nakazawa S; Kasugai Y; Ueda R; Seto M
    Cancer Sci; 2007 May; 98(5):698-706. PubMed ID: 17374122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of TEL/AML1 fusion in pediatric AML: further evidence for lineage specificity of TEL/AML1.
    Loh ML; McLean TW; Buckley JD; Howells W; Gilliland DG; Smith FO
    Leuk Res; 1998 May; 22(5):461-4. PubMed ID: 9652733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic studies on 167 pediatric ALL patients from different areas of Pakistan confirm a low frequency of the favorable prognosis fusion oncogene TEL-AML1 (t 12; 21) in underdeveloped countries of the region.
    Iqbal Z
    Asian Pac J Cancer Prev; 2014; 15(8):3541-6. PubMed ID: 24870754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TEL-AML1 fusion in relapsed childhood acute lymphoblastic leukemia.
    Seeger K; Buchwald D; Peter A; Taube T; von Stackelberg A; Schmitt G; Henze G
    Blood; 1999 Jul; 94(1):374-6. PubMed ID: 10428549
    [No Abstract]   [Full Text] [Related]  

  • 13. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines.
    Kim DH; Moldwin RL; Vignon C; Bohlander SK; Suto Y; Giordano L; Gupta R; Fears S; Nucifora G; Rowley JD
    Blood; 1996 Aug; 88(3):785-94. PubMed ID: 8704231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the Der (21)t(12;21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia.
    Kobayashi H; Satake N; Kaneko Y
    Leuk Lymphoma; 1997 Dec; 28(1-2):43-50. PubMed ID: 9498702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.
    Stams WA; den Boer ML; Beverloo HB; Meijerink JP; van Wering ER; Janka-Schaub GE; Pieters R
    Clin Cancer Res; 2005 Apr; 11(8):2974-80. PubMed ID: 15837750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood leukemia genetic bottleneck phenomenon related to TEL-AML1: the postulation by a mathematical model.
    Ivanovski P; Ivanovski I; Nikolić D; Jovanović I
    Chin Med J (Engl); 2012 Mar; 125(6):1182-5. PubMed ID: 22613552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
    Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
    Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of TEL/AML1 fusion protein in the regulation of human CR1 gene promoter.
    Song H; Kim JH; Rho JK; Park SY; Kim CG; Choe SY
    Mol Cells; 1999 Oct; 9(5):560-3. PubMed ID: 10597047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia.
    Ford AM; Bennett CA; Price CM; Bruin MC; Van Wering ER; Greaves M
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4584-8. PubMed ID: 9539781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.
    Shurtleff SA; Buijs A; Behm FG; Rubnitz JE; Raimondi SC; Hancock ML; Chan GC; Pui CH; Grosveld G; Downing JR
    Leukemia; 1995 Dec; 9(12):1985-9. PubMed ID: 8609706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.